ENCePP web header
ENCePP web header

  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Data sources

Sr. No Display Name Type Country Last Updated
1 EMBARC Data Source Transnational 04/04/2017

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Cohort Study of the Relative Incidence of Major Cardiovascular Events Among Patients Initiating Prucalopride Versus a Matched Comparator Cohort Dr Alicia Gilsenan 06/09/2021
Finalised Impact of EU label changes for hydroxyzine products: post-referral prescribing trends Professor Thomas MacDonald 06/01/2021
Finalised Impact of EU label changes for systemic diclofenac products: post-referral prescribing trends Professor Thomas MacDonald 16/02/2020
Ongoing Pregnancy outcomes in women exposed to oral cladribine: a multi-country cohort database study Dr Alejandro Arana 24/11/2022
Ongoing SARS-CoV-2 VACCINATION for COVID-19 DISEASE SAFETY STUDY (VAC4COVID STUDY) Professor Thomas MacDonald 23/11/2021
Ongoing Bendroflumethiazide versus Indapamide for Primary Hypertension: Observational (BISON) study within CPRD Professor Thomas MacDonald 13/03/2020


  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register

© 1995-2023 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI


combined emea eu logo European Medicines Agency Europa Website
Version: 4.5.3.0